glp-1 inhibitors GLP-1-based therapies, including GLP-1, GLP-1R agonists and DPP-4 Weight loss drugs – hope

They are not drugs, dietary supplements, cosmetics, or food products, and they are not for human or veterinary use, consumption, or ingestion in any form

228 NF-B confers resistance by upregulating antiapoptotic proteins (e.g., Bcl-2, Bcl-xL, XIAP, c-FLIP), stemness regulators, drug efflux transporters, and DNA repair enzymes

This process can be triggered by the activation of GPCRs in neutrophils

10.1007/s40263-024-01073-4 318 MesnageR.TeixeiraM.MandrioliD.FalcioniL.DucarmonQ

Concurrently, clinicians have observed increased conception rates among individuals using GLP-1 RAs, prompting investigation into whether these effects stem from improved metabolic health or direct pharmacologic influences on reproductive physiology